Skip to main content
. 2023 Jan 30;29(8):1468–1476. doi: 10.1158/1078-0432.CCR-22-1092

Figure 2.

Figure 2. OS in (A) the ITT population, (B) patients who were chosen to receive induction chemotherapy, (C) patients who were not chosen to receive induction chemotherapy, and (D) patients with estrogen receptor expression ≥ 10%.

OS in (A) the ITT population, (B) patients who were chosen to receive induction chemotherapy, (C) patients who were not chosen to receive induction chemotherapy, and (D) patients with estrogen receptor expression ≥ 10%.